BioGaia AB (publ)
BIOGYOTCHealthcare● Active
$11.00
+$0.00(+0.00%)
Market Cap$1.1B
P/E Ratio—
52W High$11.46
52W Low$8.79
BioGaia AB (publ) (BIOGY) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BIOGY · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.54B | $1.42B | $1.30B | $1.10B | $0.79B |
| Cost of Revenue | $0.41B | $0.39B | $0.35B | $0.30B | $0.20B |
| Gross Profit | $1.13B | $1.03B | $0.95B | $0.80B | $0.58B |
| Gross Margin %(computed) | 73.37% | 72.45% | 73.29% | 72.64% | 74.25% |
| Operating Expenses | |||||
| R&D Expenses | $0.12B | $0.16B | $0.11B | $0.11B | $0.11B |
| G&A Expenses | $0.05B | $0.04B | $0.04B | $0.04B | $0.04B |
| Total Operating Expenses | $0.72B | $0.61B | $0.51B | $0.47B | $0.34B |
| Operating Income | $0.41B | $0.42B | $0.44B | $0.36B | $0.25B |
| Operating Margin %(computed) | 26.82% | 29.76% | 34.18% | 32.74% | 32.32% |
| Interest Income | $0.02B | $0.04B | $0.04B | $0.01B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.00B | $0.01B | $0.00B |
| Income Before Tax | $0.42B | $0.45B | $0.47B | $0.45B | $0.25B |
| Income Tax Expense | $0.09B | $0.10B | $0.10B | $0.07B | $0.06B |
| Net Income | $0.33B | $0.35B | $0.37B | $0.37B | $0.20B |
| Net Margin %(computed) | 21.63% | 24.70% | 28.18% | 33.86% | 25.00% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $3.29 | $3.48 | $3.62 | $3.70 | $1.94 |
| Wtd Avg Shares | 0.10B | 0.10B | 0.10B | 0.10B | 0.10B |
| EBITDA | $0.45B | $0.54B | $0.46B | $0.48B | $0.28B |
| EBITDA Margin %(computed) | 29.54% | 37.92% | 35.13% | 43.20% | 35.26% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · SEK · B
Explore more BioGaia AB (publ) data
About BioGaia AB (publ) (BIOGY) Income Statement
BioGaia AB (publ) (BIOGY) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BIOGY reported revenue of $1.54B, gross profit of $1.13B (gross margin 73.37%), and net income of $0.33B — a net profit margin of 21.63%.
Frequently asked questions
BIOGY · 4 questionsBioGaia AB (publ) (BIOGY) reported revenue of $1.54B for 2025, up 8.1% year-over-year.
BIOGY revenueBIOGY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08